Translational control in synaptic plasticity and cognitive dysfunction

Annual Review of Neuroscience

Volumn 37, Issue , 2014, Pages 17-38

  Buffington, Shelly A ^a   Huang, Wei ^a   Costa Mattioli, Mauro ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Autism; EIF2 ; Local protein synthesis; Memory; MTOR; Neurodegeneration

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MESSENGER RNA; NERVE PROTEIN;

AUTISM; BRAIN NERVE CELL; COGNITION; COGNITIVE DEFECT; DEGENERATIVE DISEASE; FRAGILE X SYNDROME; GENE MUTATION; GENE SILENCING; HIPPOCAMPUS; HUMAN; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MEMORY; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; TRANSLATION REGULATION; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; COGNITION DISORDERS; HIPPOCAMPUS; HUMANS; MODELS, BIOLOGICAL; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; PROTEIN BIOSYNTHESIS; SIGNAL TRANSDUCTION;

EID: 84904685723     PISSN: 0147006X     EISSN: 15454126     Source Type: Book Series    
DOI: 10.1146/annurev-neuro-071013-014100     Document Type: Review

References (164)

1. Alarcon JM, Hodgman R, TheisM, Huang Y-S, Kandel ER, Richter JD. 2004. Selective modulation of some forms of Schaffer Collateral-CA1 synaptic plasticity in mice with a disruption of the CPEB-1 gene. Learn. Mem. 11:318-27
2. Antion MD, Hou L, Wong H, Hoeffer CA, Klann E. 2008. mGluR-dependent long-term depression is associated with increased phosphorylation of S6 and synthesis of elongation factor 1A but remains expressed in S6K-deficient mice. Mol. Cell. Biol. 28:2996-3007
3. Auerbach BD, Osterweil EK, Bear MF. 2011. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480:63-68
4. Bagni C, Tassone F, Neri G, Hagerman R. 2012. Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics. J. Clin. Investig. 122:4314-22
5. Banko JL, Merhav M, Stern E, Sonenberg N, Rosenblum K, Klann E. 2007. Behavioral alterations in mice lacking the translation repressor 4E-BP2. Neurobiol. Learn. Mem. 87:248-56
6. Banko JL, Poulin F, Hou L, DeMaria CT, Sonenberg N, Klann E. 2005. The translation repressor 4E-BP2 is critical for eIF4F complex formation, synaptic plasticity, and memory in the hippocampus. J. Neurosci. 25:9581-90
7. Barak S, Liu F, Hamida SB, Yowell QV, Neasta J, et al. 2013. Disruption of alcohol-related memories by mTORC1 inhibition prevents relapse. Nat. Neurosci. 16:1111-17
8. Bassell GJ, Warren ST. 2008. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 60:201-14
9. Bateup HS, Johnson CA, Denefrio CL, Saulnier JL, Kornacker K, Sabatini BL. 2013. Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis. Neuron 78:510-22
10. Bateup HS, Takasaki KT, Saulnier JL, Denefrio CL, Sabatini BL. 2011. Loss of Tsc1 in vivo impairs hippocampal mGluR-LTD and increases excitatory synaptic function. J. Neurosci. 31:8862-69
11. Bekinschtein P, Cammarota M, Igaz LM, Bevilaqua LR, Izquierdo I, Medina JH. 2007. Persistence of longterm memory storage requires a late protein synthesis- and BDNF- dependent phase in the hippocampus. Neuron 53:261-77
12. Belelovsky K, Elkobi A, Kaphzan H, Nairn AC, Rosenblum K. 2005. A molecular switch for translational control in taste memory consolidation. Eur. J. Neurosci. 22:2560-68
13. Berger-Sweeney J, Zearfoss NR, Richter JD. 2006. Reduced extinction of hippocampal-dependent memories in CPEB knockout mice. Learn. Mem. 13:4-7
14. Berlanga JJ, Ventoso I,Harding HP, Deng J, Ron D, et al. 2006. Antiviral effect of the mammalian translation initiation factor 2αkinase GCN2 against RNA viruses. EMBO J. 25:1730-40
15. Bhakar AL,D? olen G, Bear MF. 2012. The pathophysiology of fragileX(and what it teaches us about synapses). Annu. Rev. Neurosci. 35:417-43
16. Bhattacharya A, Kaphzan H, Alvarez-Dieppa AC, Murphy JP, Pierre P, Klann E. 2012. Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice. Neuron 76:325-37
17. Bidinosti M, Ran I, Sanchez-Carbente MR, Martineau Y, Gingras AC, et al. 2010. Postnatal deamidation of 4E-BP2 in brain enhances its associationwith raptor and alters kinetics of excitatory synaptic transmission. Mol. Cell 37:797-808
18. Bliss TV, Luo T. 1973. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J. Physiol. 232:381-89
19. Blundell J, Kouser M, Powell CM. 2008. Systemic inhibition of mammalian target of rapamycin inhibits fear memory reconsolidation. Neurobiol. Learn. Mem. 90:28-35
20. Bolduc FV, BellK,Cox H, BroadieKS, Tully T. 2008. Excess protein synthesis in Drosophila FragileXmutants impairs long-term memory. Nat. Neurosci. 11:1143-45
21. Busquets-Garcia A, Gomis-Gonzalez M, Guegan T, Agustin-Pav on C, Pastor A, et al. 2013. Targeting the endocannabinoid system in the treatment of fragile X syndrome. Nat. Med. 19:603-7
22. Cajigas IJ, Tushev G, Will TJ, Tom Dieck S, Fuerst N, Schuman EM. 2012. The local transcriptome in the synaptic neuropil revealed by deep sequencing and high-resolution imaging. Neuron 74:453-66
23. Cammalleri M, L? utjens R, Berton F, King AR, Simpson C, et al. 2003. Time-restricted role for dendritic activation of the mTOR-p70S6K pathway in the induction of late-phase long-term potentiation in the CA1. Proc. Natl. Acad. Sci. USA 100:14368-73
24. Cao R, Robinson B, Xu H, Gkogkas C, Khoutorsky A, et al. 2013. Translational control of entrainment and synchrony of the suprachiasmatic circadian clock by mTOR/4E-BP1 signaling. Neuron 79:712-24
25. Casadio A, Martin KC, Giustetto M, Zhu H, Chen M, et al. 1999. A transient, neuron-wide form of CREBmediated long-term facilitation can be stabilized at specific synapses by local protein synthesis. Cell 99:221-37
26. Chang RC, Suen KC, Ma CH, Elyaman W, Ng HK, Hugon J. 2002a. Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2alpha in neuronal degeneration. J. Neurochem. 83:1215-25
27. Chang RC, Wong AK, Ng HK, Hugon J. 2002b. Phosphorylation of eukaryotic initiation factor-2α(eIF2α) is associated with neuronal degeneration in Alzheimers disease. Neuroreport 13:2429-32
28. Chen A, Muzzio IA, Malleret G, Bartsch D, Verbitsky M, et al. 2003. Inducible enhancement of memory storage and synaptic plasticity in transgenic mice expressing an inhibitor of ATF4 (CREB-2) and C/EBP proteins. Neuron 39:655-69
29. Costa-MattioliM, Gobert D, Harding H, Herdy B, Azzi M, et al. 2005. Translational control of hippocampal synaptic plasticity and memory by the eIF2αkinase, GCN2. Nature 436:1166-73
30. Costa-MattioliM, Gobert D, Stern E, Gamache K, Colina R, et al. 2007. eIF2αphosphorylation bidirectionally regulates the switch from short- to long-term synaptic plasticity and memory. Cell 129:195-206
31. Costa-Mattioli M, Monteggia LM. 2013. mTOR complexes in neurodevelopmental and neuropsychiatric disorders. Nat. Neurosci. 16:1537-43
32. Costa-Mattioli M, Sossin WS, Klann E, Sonenberg N. 2009. Translational control of long-lasting synaptic plasticity and memory. Neuron 61:10-26
33. Couturier J,Morel M, Pontcharraud R, Gontier V, Fauconneau B, et al. 2010. Interaction of double-stranded RNA-dependent protein kinase (PKR) with the death receptor signaling pathway in amyloid β (Aβ)- treated cells and in APPSLPS1 knock-in mice. J. Biol. Chem. 285:1272-82
34. Couturier J, Paccalin M, MorelM, Terro F, Milin S, et al. 2011. Prevention of theβ-amyloid peptide-induced inflammatory process by inhibition of double-stranded RNA-dependent protein kinase in primarymurine mixed co-cultures. J. Neuroinflammation 8:72
35. Darnell JC, Klann E. 2013. The translation of translational control by FMRP: therapeutic targets for FXS. Nat. Neurosci. 16:1530-36
36. Darnell JC, Van Driesche SJ, Zhang C, Hung KY, Mele A, et al. 2011. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146:247-61
37. Davidkova G, Carroll RC. 2007. Characterization of the role of microtubule-associated protein 1B in metabotropic glutamate receptor-mediated endocytosis of AMPA receptors in hippocampus. J. Neurosci. 27:13273-78
38. De Rubeis S, Pasciuto E, Li KW, Fernandez E, Di Marino D, et al. 2013. CYFIP1 coordinates mRNA translation and cytoskeleton remodeling to ensure proper dendritic spine formation. Neuron 79:1169-82
39. Dever TE, Green R. 2012. The elongation, termination, and recycling phases of translation in eukaryotes. Cold Spring Harb. Perspect. Biol. 4:a013706
40. Devi CR, Ohno M. 2013. Deletion of the eIF2αkinase GCN2 fails to rescue the memory decline associated with Alzheimers disease. PLoS ONE 8:e77335
41. Dolan BM, Duron SG, Campbell DA, Vollrath B, Shankaranarayana Rao BS, et al. 2013. Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486. Proc. Natl. Acad. Sci. USA 110:5671-76
42. Doyle JP, Dougherty JD, Heiman M, Schmidt EF, Stevens TR, et al. 2008. Application of a translational profiling approach for the comparative analysis of CNS cell types. Cell 135:749-62
43. Dudai Y. 2012. The restless engram: consolidations never end. Annu. Rev. Neurosci. 35:227-47
44. Dyer JR, Michel S, Lee W, Castellucci VF, Wayne NL, Sossin WS. 2003. An activity-dependent switch to cap-independent translation triggered by eIF4E dephosphorylation. Nat. Neurosci. 6:219-20
45. Eberwine J, Belt B, Kacharmina JE, Miyashiro K. 2002. Analysis of subcellularly localized mRNAs using in situ hybridization, mRNA amplification, and expression profiling. Neurochem. Res. 27:1065-77
46. Ehninger D, Han S, Shilyansky C, Zhou Y, LiW, et al. 2008. Reversal of learning deficits in a Tsc2+/? mouse model of tuberous sclerosis. Nat. Med. 14:843-48
47. Ehninger D, Silva AJ. 2011. Rapamycin for treating tuberous sclerosis and autism spectrum disorders. Trends Mol. Med. 17:78-87
48. Endersby R, Baker SJ. 2008. PTEN signaling in brain: neuropathology and tumorigenesis. Oncogene 27:5416-30
49. Fombonne E. 1999. The epidemiology of autism: a review. Psychol. Med. 29:769-86
50. Frey U, Morris RG. 1997. Synaptic tagging and long-term potentiation. Nature 385:533-36
51. Garcia MA, Meurs EF, Esteban M. 2007. The dsRNA protein kinase PKR: virus and cell control. Biochimie 89:799-811
52. Gildish I, Manor D, David O, Sharma V, Williams D, et al. 2012. Impaired associative taste learning and abnormal brain activation in kinase-defective eEF2K mice. Learn. Mem. 19:116-25
53. Gingras AC, Raught B, Sonenberg N. 2004. mTOR signaling to translation. Curr. Top. Microbiol. Immunol. 279:169-97
54. Gkogkas CG, Khoutorsky A, Ran I, Rampakakis E, Nevarko T, et al. 2013. Autism-related deficits via dysregulated eIF4E-dependent translational control. Nature 493:371-77
55. Goorden SM, van Woerden GM, van der Weerd L, Cheadle JP, Elgersma Y. 2007. Cognitive deficits in Tsc1+/? mice in the absence of cerebral lesions and seizures. Ann. Neurol. 62:648-55
56. Govindarajan A, Israely I, Huang S-Y, Tonegawa S. 2011. The dendritic branch is the preferred integrative unit for protein synthesis-dependent LTP. Neuron 69:132-46
57. Hay N, Sonenberg N. 2004. Upstream and downstream of mTOR. Genes Dev. 18:1926-45
58. Hayashi ML, Choi SY, Rao BS, Jung HY, Lee HK, et al. 2004. Altered cortical synaptic morphology and impaired memory consolidation in forebrain-specific dominant-negative PAK transgenic mice. Neuron 42:773-87
59. Henry FE, McCartney AJ, Neely R, Perez AS, Carruthers CJ, et al. 2012. Retrograde changes in presynaptic function driven by dendritic mTORC1. J. Neurosci. 32:17128-42
60. Hinnebusch AG. 2005. Translational regulation of GCN4 and the general amino acid control of yeast. Annu. Rev. Microbiol. 59:407-50
61. Hoeffer CA, Cowansage KK, Arnold EC, Banko JL, Moerke NJ, et al. 2011. Inhibition of the interactions between eukaryotic initiation factors 4E and 4G impairs long-term associative memory consolidation but not reconsolidation. Proc. Natl. Acad. Sci. USA 108:3383-88
62. HoefferCA, Sanchez E,Hagerman RJ,MuY, Nguyen DV, et al. 2012. AlteredmTORsignaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome. Genes Brain Behav. 11:332-41
63. HoefferCA, Santini E,MaT, Arnold EC, Whelan AM, et al. 2013. Multiple components of eIF4F are required for protein synthesis-dependent hippocampal long-term potentiation. J. Neurophysiol. 109:68-76
64. Hou L, Klann E. 2004. Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression. J. Neurosci. 24:6352-61
65. Hsieh AC, Liu Y, Edlind MP, Ingolia NT, Janes MR, et al. 2012. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 485:55-61
66. Huang F, Chotiner JK, Steward O. 2005. The mRNA for elongation factor 1αis localized in dendrites and translated in response to treatments that induce long-term depression. J. Neurosci. 25:7199-209
67. HuangW, Zhu PJ, Zhang S, Zhou H, Stoica L, et al. 2013. mTORC2 controls actin polymerization required for consolidation of memory. Nat. Neurosci. 16:441-48
68. Huang YS, Jung MY, Sarkissian M, Richter JD. 2002. N-methyl-D-aspartate receptor signaling results in Aurora kinase-catalyzed CPEB phosphorylation and alpha CaMKII mRNA polyadenylation at synapses. EMBO J. 21:2139-48
69. Huang YS, Kan MC, Lin CL, Richter JD. 2006. CPEB3 and CPEB4 in neurons: analysis of RNA-binding specificity and translational control of AMPA receptor GluR2 mRNA. EMBO J. 25:4865-76
70. Huber KM, Kayser MS, Bear MF. 2000. Role for rapid dendritic protein synthesis in hippocampal mGluRdependent long-term depression. Science 288:1254-57
71. IngoliaNT,Ghaemmaghami S,NewmanJRS,Weissman JS. 2009. Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science 324:218-23
72. Jackson RJ, Hellen CU, Pestova TV. 2010. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat. Rev. Mol. Cell Biol. 11:113-27
73. JacksonRJ, HellenCU, PestovaTV. 2012. Termination and post-termination events in eukaryotic translation. Adv. Protein Chem. Struct. Biol. 86:45-93
74. Jakawich SK, Nasser HB, Strong MJ, McCartney AJ, Perez AS, et al. 2010. Local presynaptic activity gates homeostatic changes in presynaptic function driven by dendritic BDNF synthesis. Neuron 68:1143-58
75. Jiang Z, Belforte JE, Lu Y, Yabe Y, Pickel J, et al. 2010. eIF2α phosphorylation-dependent translation in CA1 pyramidal cells impairs hippocampal memory consolidation without affecting general translation. J. Neurosci. 30:2582-94
76. Kandel ER. 2001. The molecular biology of memory storage: a dialogue between genes and synapses. Science 294:1030-38
77. Kang H, Schuman EM. 1996. A requirement for local protein synthesis in neurotrophin-induced hippocampal synaptic plasticity. Science 273:1402-6
78. Karim MM, Svitkin YV, Kahvejian A, De Crescenzo G, Costa-MattioliM, Sonenberg N. 2006. A mechanism of translational repression by competition of Paip2 with eIF4G for poly(A) binding protein (PABP) binding. Proc. Natl. Acad. Sci. USA 103:9494-99
79. Khaleghpour K, Kahvejian A, De Crescenzo G, Roy G, Svitkin YV, et al. 2001. Dual interactions of the translational repressor Paip2 with poly(A) binding protein. Mol. Cell. Biol. 21:5200-13
80. Khandjian EW, Corbin F,Woerly S, Rousseau F. 1996. The fragile X mental retardation protein is associated with ribosomes. Nat. Genet. 12:91-93
81. Khoutorsky A, Yanagiya A, Gkogkas CG, Fabian MR, Prager-KhoutorskyM, et al. 2013. Control of synaptic plasticity and memory via suppression of poly(A)-binding protein. Neuron 78:298-311
82. Kr? uttner S, Stepien B, Noordermeer JN, Mommaas MA, Mechtler K, et al. 2012. Drosophila CPEB Orb2A mediates memory independent of its RNA-binding domain. Neuron 76:383-95
83. Kwon CH, Luikart BW, Powell CM, Zhou J, Matheny SA, et al. 2006. Pten regulates neuronal arborization and social interaction in mice. Neuron 50:377-88
84. Laggerbauer B, OstareckD, Keidel EM, Ostareck-Lederer A, Fischer U. 2001. Evidence that fragile Xmental retardation protein is a negative regulator of translation. Hum. Mol. Genet. 10:329-38
85. Langstrom NS, Anderson JP, Lindroos HG,Winblad B, Wallace WC. 1989. Alzheimers disease-associated reduction of polysomal mRNA translation. Brain Res. Mol. Brain Res. 5:259-69
86. Laplante M, Sabatini DM. 2012. mTOR signaling in growth control and disease. Cell 149:274-93
87. Laurenco MV, Clarke JR, Frozza RL, Bomfim TR, Forny-Germano L, et al. 2013. TNF-αmediates PKRdependentmemory impairment and brain IRS-1 inhibition induced by Alzheimers β-amyloid oligomers in mice and monkeys. Cell Metab. 18:831-43
88. Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, et al. 2007. Genome-wide atlas of gene expression in the adult mouse brain. Nature 445:168-76
89. Li Z, Zhang Y, Ku L, Wilkinson KD, Warren ST, Feng Y. 2001. The fragile X mental retardation protein inhibits translation via interacting with mRNA. Nucleic Acids Res. 29:2276-83
90. Lu PD, Harding HP, Ron D. 2004. Translation reinitiation at alternative open reading frames regulates gene expression in an integrated stress response. J. Cell Biol. 167:27-33
91. L? uscher C, Huber KM. 2010. Group 1 mGluR-dependent synaptic long-term depression: mechanisms and implications for circuitry and disease. Neuron 65:445-59
92. Ma T, Trinh MA, Wexler AJ, Bourbon C, Gatti E, et al. 2013. Suppression of eIF2α kinases alleviates Alzheimers disease-related plasticity and memory deficits. Nat. Neurosci. 16:1299-305
93. Ma XM, Blenis J. 2009. Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol. 10:307-18
94. Majumdar A, Cesario WC, White-Grindley E, Jiang H, Ren F, et al. 2012. Critical role of amyloid-like oligomers of Drosophila Orb2 in the persistence of memory. Cell 148:515-29
95. Malenka RC, Bear MF. 2004. LTP and LTD: an embarrassment of riches. Neuron 44:5-21
96. Martin KC, Casadio A, Zhu H, Yaping E, Rose JC, et al. 1997. Synapse-specific, long-term facilitation of Aplysia sensory tomotor synapses: a function for local protein synthesis in memory storage. Cell 91:927-38
97. Martin KC, Ephrussi A. 2009. mRNA localization: gene expression in the spatial dimension. Cell 136:719-30
98. McGaugh JL. 2000. Memory-a century of consolidation. Science 287:248-51
99. Mefford HC, BatshawML, Hoffman EP. 2012. Genomics, intellectual disability, and autism. N. Engl. J.Med. 366:733-43
100. Milekic MH, Alberini CM. 2002. Temporally graded requirement for protein synthesis following memory reactivation. Neuron 36:521-25
101. Miniaci MC, Kim JH, Puthanveettil SV, Si K, Zhu H, et al. 2008. Sustained CPEB-dependent local protein synthesis is required to stabilize synaptic growth for persistence of long-term facilitation in Aplysia. Neuron 59:1024-36
102. Morel M, Couturier J, Lafay-Chebassier C, Paccalin M, Page G. 2009. PKR, the double stranded RNAdependent protein kinase as a critical target in Alzheimers disease. J. Cell. Mol. Med. 13:1476-88
103. Muddashetty RS, Kelic S, Gross C, Xu M, Bassell GJ. 2007. Dysregulated metabotropic glutamate receptordependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome. J. Neurosci. 27:5338-48
104. Nader K, Schafe GE, Le Doux JE. 2000. Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval. Nature 406:722-26
105. Napoli I, Mercaldo V, Boyl PP, Eleuteri B, Zalfa F, et al. 2008. The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP. Cell 134:1042-54
106. Nelson DL, Orr HT,Warren ST. 2013. The unstable repeats-three evolving faces of neurological disease. Neuron 77:825-43
107. Neves G, Cooke SF, Bliss TV. 2008. Synaptic plasticity, memory and the hippocampus: a neural network approach to causality. Nat. Rev. Neurosci. 9:65-75
108. OConnor T, Sadleir KR, Maus E, Velliquette RA, Zhao J, et al. 2008. Phosphorylation of the translation initiation factor eIF2αincreases BACE1 levels and promotes amyloidogenesis. Neuron 60:988-1009
109. ORoak BJ, Vives L, Fu W, Egertson JD, Stanaway IB, et al. 2012. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 338:1619-22
110. Onuki R, Bando Y, Suyama E, Katayama T, Kawasaki H, et al. 2004. An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimers disease. EMBO J. 23:959-68
111. Page G, Rioux Bilan A, Ingrand S, Lafay-Chebassier C, Pain S, et al. 2006. Activated double-stranded RNAdependent protein kinase and neuronal death in models of Alzheimers disease. Neuroscience 139:1343-54
112. Park S, Park JM,Kim S, Kim JA, Shepherd JD, et al. 2008. Elongation factor 2 and fragile Xmental retardation protein control the dynamic translation of Arc/Arg3.1 essential for mGluR-LTD. Neuron 59:70-83
113. Pavitt GD, Ramaiah KV, Kimball SR, Hinnebusch AG. 1998. eIF2 independently binds two distinct eIF2B subcomplexes that catalyze and regulate guanine-nucleotide exchange. Genes Dev. 12:514-26
114. Penney J,TsurudomeK, Liao EH, Elazzouzi F, Livingstone M, et al. 2012.TORis required for the retrograde regulation of synaptic homeostasis at the Drosophila neuromuscular junction. Neuron 74:166-78
115. Poon MM, Choi SH, Jamieson CA, Geschwind DH, Martin KC. 2006. Identification of process-localized mRNAs from cultured rodent hippocampal neurons. J. Neurosci. 26:13390-99
116. Qin M, Kang J, Burlin TV, Jiang C, Smith CB. 2005. Postadolescent changes in regional cerebral protein synthesis: an in vivo study in the FMR1 null mouse. J. Neurosci. 25:5087-95
117. Ran I, Gkogkas CG, Vasuta C, Tartas M, Khoutorsky A, et al. 2013. Selective regulation of GluA subunit synthesis and AMPA receptor-mediated synaptic function and plasticity by the translation repressor 4EBP2 in hippocampal pyramidal cells. J. Neurosci. 33:1872-86
118. Redondo RL, Morris RGM. 2011. Making memories last: the synaptic tagging and capture hypothesis. Nat. Rev. Neurosci. 12:17-30
119. Richter JD, KlannE. 2009. Making synaptic plasticity and memory last: mechanisms of translational regulation. Genes Dev. 23:1-11
120. Ron D, Harding HP. 2007. eIF2α phosphorylation in cellular stress responses and disease. In Translational Control in Biology and Medicine, ed. MB Mathews, N Sonenberg, JWB Hershey, pp. 345-68. Cold Spring Harbor, NY: Cold Spring Harbor Lab. Press
121. Ruvinsky I, Sharon N, Lerer T, Cohen H, Stolovich-Rain M, et al. 2005. Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis. Genes Dev. 19:2199-211
122. Sahin M. 2012. Targeted treatment trials for tuberous sclerosis and autism: no longer a dream. Curr. Opin. Neurobiol. 22:895-901
123. Santini E,Huynh TN,MacAskill AF, Carter AG, Pierre P, et al. 2013. Exaggerated translation causes synaptic and behavioural aberrations associated with autism. Nature 493:411-15
124. Sharma A,Hoeffer CA, Takayasu Y,Miyawaki T,McBride SM, et al. 2010. Dysregulation ofmTOR signaling in fragile X syndrome. J. Neurosci. 30:694-702
125. Shires KL, Da Silva BM, Hawthorne JP, Morris RG, Martin SJ. 2012. Synaptic tagging and capture in the living rat. Nat. Commun. 3:1246
126. Si K, Choi Y-B, White-Grindley E, Majumdar A, Kandel ER. 2010. Aplysia CPEB can form prion-like multimers in sensory neurons that contribute to long-term facilitation. Cell 140:421-35
127. Si K, Giustetto M, Etkin A, Hsu R, Janisiewicz AM, et al. 2003a. A neuronal isoform of CPEB regulates local protein synthesis and stabilizes synapse-specific long-term facilitation in Aplysia. Cell 115:893-904
128. Si K, Lindquist S, Kandel ER. 2003b. A neuronal isoform of the Aplysia CPEB has prion-like properties. Cell 115:879-91
129. Sidrauski C, Acosta-Alvear D, Khoutorsky A, Vedantham P, Hearn BR, et al. 2013. Pharmacological brakerelease of mRNA translation enhances cognitive memory. eLife 2:e00498
130. Silva AJ, Paylor R, Wehner JM, Tonegawa S. 1992a. Impaired spatial learning in alpha-calcium-calmodulin kinase II mutant mice. Science 257:206-11
131. Silva AJ, Stevens CF, Tonegawa S, Wang Y. 1992b. Deficient hippocampal long-term potentiation in alphacalcium- calmodulin kinase II mutant mice. Science 257:201-6
132. Sonenberg N, Hinnebusch AG. 2009. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 136:731-45
133. Stefani G, Fraser CE, Darnell JC, Darnell RB. 2004. Fragile X mental retardation protein is associated with translating polyribosomes in neuronal cells. J. Neurosci. 24:7272-76
134. Stern E, Chinnakkaruppan A, David O, Sonenberg N, Rosenblum K. 2013. Blocking the eIF2αkinase (PKR) enhances positive and negative forms of cortex-dependent taste memory. J. Neurosci. 33:2517-25
135. Steward O. 1997. mRNA localization in neurons: a multipurpose mechanism? Neuron 18:9-12
136. Steward O, Levy WB. 1982. Preferential localization of polyribosomes under the base of dendritic spines in granule cells of the dentate gyrus. J. Neurosci. 2:284-91
137. Steward O, Schuman EM. 2001. Protein synthesis at synaptic sites on dendrites. Annu. Rev. Neurosci. 24:299-325
138. Stoica L, Zhu PJ, Huang W, Zhou H, Kozma SC, Costa-Mattioli M. 2011. Selective pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage. Proc. Natl. Acad. Sci. USA 108:3791-96
139. SuttonMA, ItoHT, Cressy P, KempfC,Woo JC, Schuman EM. 2006. Miniature neurotransmission stabilizes synaptic function via tonic suppression of local dendritic protein synthesis. Cell 125:785-99
140. SuttonMA, Schuman EM. 2006. Dendritic protein synthesis, synaptic plasticity, and memory. Cell 127:49-58
141. Sutton MA, Taylor AM, Ito HT, Pham A, Schuman EM. 2007. Postsynaptic decoding of neural activity: eEF2 as a biochemical sensor coupling miniature synaptic transmission to local protein synthesis. Neuron 55:648-61
142. SuttonMA, Wall NR, Aakalu GN, Schuman EM. 2004. Regulation of dendritic protein synthesis by miniature synaptic events. Science 304:1979-83
143. Swanger SA, Bassell GJ. 2011. Making and breaking synapses through local mRNA regulation. Curr. Opin. Genet. Dev. 21:414-21
144. Taha E, Gildish I, Gal-Ben-Ari S, Rosenblum K. 2013. The role of eEF2 pathway in learning and synaptic plasticity. Neurobiol. Learn. Mem. 105:100-6
145. Takei N, Kawamura M, Hara K, Yonezawa K, Nawa H. 2001. Brain-derived neurotrophic factor enhances neuronal translation by activating multiple initiation processes: comparison with the effects of insulin. J. Biol. Chem. 276:42818-25
146. Takeuchi K, GertnerMJ, Zhou J, Parada LF,BennettMV,Zukin RS. 2013. Dysregulation of synaptic plasticity precedes appearance of morphological defects in a Pten conditional knockout mouse model of autism. Proc. Natl. Acad. Sci. USA 110:4738-43
147. Tang SJ, Reis G, Kang H, Gingras AC, Sonenberg N, Schuman EM. 2002. A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus. Proc. Natl. Acad. Sci. USA 99:467-72
148. Thoreen CC, Chantranupong L, Keys HR, Wang T, Gray NS, Sabatini DM. 2012. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 485:109-13
149. Trinh MA, Kaphzan H, Wek RC, Pierre P, Cavener DR, Klann E. 2012. Brain-specific disruption of the eIF2αkinase PERK decreases ATF4 expression and impairs behavioral flexibility. Cell Rep. 1:676-88
150. Tsokas P, Grace EA, Chan P,Ma T, Sealfon SC, et al. 2005. Local protein synthesis mediates a rapid increase in dendritic elongation factor 1A after induction of late long-term potentiation. J. Neurosci. 25:5833-43
151. Tsokas P, Ma T, Iyengar R, Landau EM, Blitzer RD. 2007. Mitogen-activated protein kinase upregulates the dendritic translation machinery in long-term potentiation by controlling the mammalian target of rapamycin pathway. J. Neurosci. 27:5885-94
152. Tsukiyama-Kohara K, Poulin F, Kohara M, DeMaria CT, Cheng A, et al. 2001. Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1. Nat. Med. 7:1128-32
153. Udagawa T, Farney NG, Jakovcevski M, Kaphzan H, Alarcon JM, et al. 2013. Genetic and acute CPEB1 depletion ameliorate fragile X pathophysiology. Nat. Med. 19:1473-77
154. Udagawa T, Swanger SA, Takeuchi K, Kim JH, Nalavadi V, et al. 2012. Bidirectional control of mRNA translation and synaptic plasticity by the cytoplasmic polyadenylation complex. Mol. Cell 47:253-66
155. Vattem KM, Wek RC. 2004. Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells. Proc. Natl. Acad. Sci. USA 101:11269-74
156. Viana Di Prisco G, Huang W, Buffington SA, Hsu C-C, Bonnen P, et al. 2014. Translational control of mGluR-dependent long-term depression and object-place learning by eIF2α. Nat. Neurosci. In press
157. Wang DO, Martin KC, Zukin RS. 2010a. Spatially restricting gene expression by local translation at synapses. Trends Neurosci. 33:173-82
158. Wang X, Luo YX, He YY, Li FQ, Shi HS, et al. 2010b. Nucleus accumbens core mammalian target of rapamycin signaling pathway is critical for cue-induced reinstatement of cocaine seeking in rats. J. Neurosci. 30:12632-41
159. Weatherill DB, Dyer J, SossinWS. 2010. Ribosomal protein S6 kinase is a critical downstream effector of the target of rapamycin complex 1 for long-term facilitation in Aplysia. J. Biol. Chem. 285:12255-67
160. Weatherill DB,McCamphill PK, Pethoukov E, Dunn TW, Fan X, SossinWS. 2011. Compartment-specific, differential regulation of eukaryotic elongation factor 2 and its kinase within Aplysia sensory neurons. J. Neurochem. 117:841-55
161. Wu L, Wells D, Tay J,Mendis D, AbbottMA, et al. 1998. CPEB-mediated cytoplasmic polyadenylation and the regulation of experience-dependent translation ofα-CaMKIImRNA at synapses. Neuron 21:1129-39
162. Wullschleger S, Loewith R, Hall MN. 2006. TOR signaling in growth and metabolism. Cell 124:471-84
163. Zhu PJ, Huang W, Kalikulov D, Yoo JW, Placzek AN, et al. 2011. Suppression of PKR promotes network excitability and enhanced cognition by interferon-?-mediated disinhibition. Cell 147:1384-96
164. Zoghbi HY, Bear MF. 2012. Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. Cold Spring Harb. Perspect. Biol. 4(3):a009886